15 February 2017 – Hyflux Ltd (Hyflux) today signed an agreement with Changi General Hospital (CGH) to conduct two clinical trials to establish the effectiveness of Hyflux’s ELO Water and ELO Gel on diabetes control and diabetic foot ulcer patients.
The trials will study whether patients with diabetes can obtain better glycaemic control by drinking ELO Water in addition to their ongoing lifestyle and medical treatments, and whether diabetic foot or ankle ulcers can be treated with ELO Water bath and ELO Gel. Dr Joan Khoo, Senior Consultant and Chief of Endocrinology at CGH, is the principal investigator of both trials. Please refer to Annex 1 for details of the trials’ study protocols.
Subcribe to our mailing list to get the updates to your email inbox...
Best viewed on IE 11, Firefox 27, Chrome 22, and Safari 7 and above.